05/07/2024
3:46 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:35 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:36 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
3:41 PM | Kiniksa Pharmaceuticals (Filer)
| Form ARS | |
04/23/2024
3:43 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
3:46 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/10/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/08/2024
4:20 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:21 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:17 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:18 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
4:19 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/03/2024
4:22 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:23 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:25 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:32 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/11/2024
6:05 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:37 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:24 PM | Kiniksa Pharmaceuticals (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:29 PM | Kiniksa Pharmaceuticals (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024
6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:46 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Kiniksa Pharmaceuticals (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
01/04/2024
6:37 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
3:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:20 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
3:46 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:33 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023
6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:26 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:03 PM | Kiniksa Pharmaceuticals (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:04 PM | Kiniksa Pharmaceuticals (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Urgent Nvidia Warning (Ad) Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… |
09/06/2023
6:06 PM | Kiniksa Pharmaceuticals (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:06 PM | Kiniksa Pharmaceuticals (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:07 PM | Kiniksa Pharmaceuticals (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
6:08 PM | Kiniksa Pharmaceuticals (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
4:26 PM | Kiniksa Pharmaceuticals (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/25/2023
6:40 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Cole G Bradley (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:15 PM | Kiniksa Pharmaceuticals (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:37 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:09 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
